Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CCND1 inhibitors(Cyclin D1 inhibitors), CTNNB1 inhibitors(Catenin beta 1 inhibitors), WNT6 inhibitors(Wnt family member 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis-Associated Neoplasms | Preclinical | China | 01 Jan 2026 |





